Zoonotic Disease Treatment Market

Future Market Insights

Key Insight

The zoonotic disease treatment market is projected to grow from USD 46.4 billion in 2025 to USD 82.3 billion by 2035, at a CAGR of 5.9%. Rabies will dominate with a 30.5% market share, while antibacterial will lead the drug class segment with a 35.0% share.

August 08, 2025

Anurag Sharma

250 Pages

Cite this Report

Zoonotic Disease Treatment Market

https://www.futuremarketinsights.com/reports/zoonotic-disease-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

BlackRock
BioCryst Pharmaceuticals
Cadila Healthcare Limited
F. Hoffmann-La Roche Ag
GSK
Johnson
Novartis International AG
The Vanguard Group
L'Oréal
Sun Pharmaceuticals Industries Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Zoonotic Disease Treatment Market

Key Players

Similar Industry Reports